Literature DB >> 8541939

Legionnaires' disease surveillance: England and Wales 1994.

C A Joseph1, E J Hutchinson, D Dedman, R J Birtles, J M Watson, C L Bartlett.   

Abstract

One hundred and sixty cases of legionnaires' disease in England and Wales were reported to the PHLS Communicable Disease Surveillance Centre in 1994, a rate of 3.1 cases per million population. Twenty-seven cases died. Eighty-nine cases (56%) were associated with travel, either in the United Kingdom (UK) or abroad, and six with a stay in hospital; the remaining cases were presumed to have acquired infection in the community. Seven outbreaks were detected in England and Wales: one was associated with a holiday centre, one with a hotel in London, two with industrial sites, and three occurred in the community. A further four clusters were associated with travel abroad: Spain, Ibiza, the Channel Islands, and a Mediterranean cruise. One hundred and twenty-eight of the 160 cases (79%) were sporadic--that is, not known to be associated with outbreaks--43 of which (34%) were not associated with travel nor acquired in hospital.

Entities:  

Mesh:

Year:  1995        PMID: 8541939

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  3 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  An international investigation of an outbreak of Legionnaires disease among UK and French tourists.

Authors:  C Joseph; D Morgan; R Birtles; C Pelaz; C Martín-Bourgón; M Black; I Garcia-Sanchez; M Griffin; N Bornstein; C Bartlett
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

3.  Legionella species colonization of water distribution systems, pools and air conditioning systems in cruise ships and ferries.

Authors:  Georgia Goutziana; Varvara A Mouchtouri; Maria Karanika; Antonios Kavagias; Nikolaos E Stathakis; Kostantinos Gourgoulianis; Jenny Kremastinou; Christos Hadjichristodoulou
Journal:  BMC Public Health       Date:  2008-11-24       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.